Ronaktolol
Изглед
Nazivi | |
---|---|
IUPAC naziv
N-[4-[2-Hidroksi-3-(propan-2-ilamino)propoksi]fenil]-4-metoksibenzamid
| |
Identifikacija | |
3D model (Jmol)
|
|
ChemSpider | |
UNII | |
| |
Svojstva | |
C20H26N2O4 | |
Molarna masa | 358,44 g·mol−1 |
Ukoliko nije drugačije napomenuto, podaci se odnose na standardno stanje materijala (na 25 °C [77 °F], 100 kPa). | |
Reference infokutije | |
Ronactolol je antagonist beta adrenergičkog receptora.[3]
Reference
[уреди | уреди извор]- ^ Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today. 15 (23-24): 1052—7. PMID 20970519. doi:10.1016/j.drudis.2010.10.003.
- ^ Evan E. Bolton; Yanli Wang; Paul A. Thiessen; Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry. 4: 217—241. doi:10.1016/S1574-1400(08)00012-1.
- ^ Mannucci, C; Caviglioli, G; Perico, A; Triolo, A (1992). „High-performance liquid chromatographic method for determination of ronactolol in urine and plasma: Evaluation of pharmacokinetic parameters in healthy humans”. Journal of Pharmaceutical Sciences. 81 (6): 556—8. PMID 1355791. doi:10.1002/jps.2600810618.